Methyl 5-hydroxytetrahydro-2H-pyran-3-carboxylate

Catalog No. :
ACKNBG748
CAS No. :
1207624-83-6
Molecular Formula :
C7H12O4
Molecular Weight :
160.17

IUPAC Name:methyl 5-hydroxytetrahydro-2H-pyran-3-carboxylate

Methyl 5-hydroxytetrahydro-2H-pyran-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$393.00Login to see priceIn stockInquiry
250mg95%$630.00Login to see priceIn stockInquiry
500mg95%$1049.00Login to see priceInquiryInquiry
1g95%$1571.00Login to see priceInquiryInquiry
5g95%$4712.00Login to see priceInquiryInquiry
10g95%$8011.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-hydroxytetrahydro-2H-pyran-3-carboxylate
IUPAC Namemethyl 5-hydroxytetrahydro-2H-pyran-3-carboxylate
MDL No.MFCD24503858
Molecular FormulaC7H12O4
Molecular Weight160.17
SMILESO=C(C1COCC(O)C1)OC
InChI KeyTVDGYINOOUKBLT-UHFFFAOYSA-N
Synonymmethyl 5-hydroxyoxane-3-carboxylate | 1207624-83-6 | Methyl 5-hydroxytetrahydro-2H-pyran-3-carboxylate | erythro-Pentitol, 1,5-anhydro-2,3-dideoxy-2-(methoxycarbonyl)- | trans-methyl 5-hydroxytetrahydro-2H-pyran-3-carboxylate | SCHEMBL4640213 | MFCD245038
CAS No.1207624-83-6
PubChem CID57452017

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKNBG748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVUCA945 route compound structure diagram
    ACVUCA945127956-19-8
  2. Then
  3. ACKNBG748 route product structure diagram
    ACKNBG7481207624-83-6 In Stock
Inquiry

2. ACKNBG748 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKNBG748 route product structure diagram
    ACKNBG7481207624-83-6 In Stock
Inquiry

Comments (0)